Literature DB >> 30605729

The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.

Valentina Tassinari1, Valeriana Cesarini1, Domenico Alessandro Silvestris1, Angela Gallo2.   

Abstract

A-to-I RNA editing is a post-transcriptional mechanism that converts the genomically coded Adenosine (A) into Inosine (I) at the RNA level. This type of RNA editing is the most frequent in humans and is mediated by the ADAR enzymes. RNA editing can alter the genetic code of mRNAs, but also affect the functions of noncoding RNAs such as miRNAs. Recent studies have identified thousands of microRNA editing events in different cancer types. However, the important role played by miRNA-editing in cancer has been reported for just a few microRNAs. Herein, we recapitulate the current studies on cancer-related microRNA editing and discuss their importance in tumor growth and progression. This article is part of a Special Issue entitled: mRNA modifications in gene expression control edited by Dr. Soller Matthias and Dr. Fray Rupert.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30605729     DOI: 10.1016/j.bbagrm.2018.12.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  9 in total

Review 1.  Complexity in regulating microRNA biogenesis in cancer.

Authors:  Pai-Sheng Chen; Shao-Chieh Lin; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-19

2.  ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis.

Authors:  Zhou Shangxun; Li Junjie; Zhao Wei; Wang Yutong; Jia Wenyuan; Liu Shanshou; Wang Yanjun; Wang Qianmei; Feng Zhusheng; Yu Chaoping; Zhuang Ran; Yin Wen; Huang Yang
Journal:  Mediators Inflamm       Date:  2020-03-24       Impact factor: 4.711

3.  MicroRNA-186-5p Inhibits Proliferation And Metastasis Of Esophageal Cancer By Mediating HOXA9.

Authors:  Changqin Xu; Bin Li; Shulei Zhao; Bingjie Jin; Ruzhen Jia; Jian Ge; Hongwei Xu
Journal:  Onco Targets Ther       Date:  2019-10-30       Impact factor: 4.147

4.  MicroRNA editing patterns in Huntington's disease.

Authors:  Shiyong Guo; Jun Yang; Bingbing Jiang; Nan Zhou; Hao Ding; Guangchen Zhou; Shuai Wu; Angbaji Suo; Xingwang Wu; Wenping Xie; Wanran Li; Yulong Liu; Wei Deng; Yun Zheng
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

5.  REIA: A database for cancer A-to-I RNA editing with interactive analysis.

Authors:  Huimin Zhu; Lu Huang; Songbin Liu; Zhiming Dai; Zhou Songyang; Zhihui Weng; Yuanyan Xiong
Journal:  Int J Biol Sci       Date:  2022-03-14       Impact factor: 6.580

Review 6.  Autophagy in cancers including brain tumors: role of MicroRNAs.

Authors:  Mohammad Hossein Pourhanifeh; Maryam Mahjoubin-Tehran; Mohammad Reza Karimzadeh; Hamid Reza Mirzaei; Zahra Sadat Razavi; Amirhossein Sahebkar; Nayyerehsadat Hosseini; Hamed Mirzaei; Michael R Hamblin
Journal:  Cell Commun Signal       Date:  2020-06-09       Impact factor: 5.712

7.  Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism.

Authors:  Jiadeng Chao; Lei Jin; Xudong Zhang; Dong Ding; Siyuan Wu; Le Ma; Bei Zhu; Shiting Shan; Xiao Yun; Peng Gao; Jun Li; Chunfu Zhu; Xihu Qin
Journal:  Oncol Lett       Date:  2019-11-19       Impact factor: 2.967

Review 8.  Deciphering miRNAs' Action through miRNA Editing.

Authors:  Marta Correia de Sousa; Monika Gjorgjieva; Dobrochna Dolicka; Cyril Sobolewski; Michelangelo Foti
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

Review 9.  RNA editing in mesothelioma: a look forward.

Authors:  Ananya Hariharan; Suna Sun; Martin Wipplinger; Emanuela Felley-Bosco
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.